KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Chemistry / 2015 / Cilt: 39 - Sayı: 1

Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II)

Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-K N3} zinc(II)

Hasan KÜÇÜKBAY
Ülkü YILMAZ
Mehmet AKKURT
Orhan BÜYÜKGÜNGÖR
Sayfa
108–120
Yayın Tarihi
2015-03-15
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses.
📊
Temel Bulgular & Veri:The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M.
💡
Sonuç & Katkı:Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Benzimidazole metal complexes · transition metal complexes · coordination compounds

Özet

The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses. The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M. Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

Abstract

The Co(II), Fe(II), and Zn(II) complexes of 1-(3-phenyl)propylbenzimidazole (PPBI), 5-nitro-1-(3-phenyl) propylbenzimidazole (PPNBI), 1-[2-(4-morpholinyl)ethyl]benzimidazole (MEBI), 1-[2-(1-piperidinyl)ethyl]benzimidazole (PEBI), and 5-nitro-1-[2-(1-piperidinyl)ethyl]benzimidazole (PENBI) were synthesized and characterized by 1H NMR, 13C NMR, and elemental analyses. The magnitudes of the magnetic moments for paramagnetic complexes were between 4.07 and 5.11 B.M. Moreover, the crystal structure of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II) was determined by single crystal X-ray diffraction.

🔖

Bu Makaleye Atıf Yap

KÜÇÜKBAY, H., YILMAZ, Ü., AKKURT, M., BÜYÜKGÜNGÖR, O. (2015). Synthesis and characterization of substituted benzimidazole Co(II), Fe(II), and Zn(II) complexes and structural characterization of dichlorobis{1-[2-(1-piperidinyl)ethyl]-1H-benzimidazole-KN3} zinc(II). Turkish Journal of Chemistry, Cilt: 39 - Sayı: 1, 108–120. https://ajindex.com/articles/184735

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Barros-Garcia, F. J.; Bernalte-Garcia, A.; Luna-Giles, F.; Maldonado-Rogado, M. A.; Vinuelas-Zahinos, E. Poly hedron 2005, 24, 1764–1772.
  2. Reedijk, J. Comprehensive Coordination Chemistry, Vol. 2; Pergamon: Oxford, UK, 1987, pp. 73–98.
  3. Preston, P. N. Benzimidazole and Congeneric Tricyclic Compounds, Part-2; Wiley: New York, NY, USA, 1980, pp. 531–543.
  4. Roopashree, B.; Gayathri, V.; Gopi, A.; Devaraju, K. S. J. Coord. Chem. 2012, 65, 4023–4040.
  5. Khalil, M. M. H.; Ali, S. A.; Ramadan, R. M. Spectrochimica Acta A 2001, 57, 1017–1024.
  6. Ahuja, I. S.; Prasad, I. Inorg. Nucl. Chem. Lett. 1976, 12, 777–784.
  7. Wu, H.; Yuan, J.; Bal, Y.; Pan, G.; Wang, H.; Shao, J.; Gao, J.; Wang. Y. J. Coord. Chem. 2012, 65, 4327–4341.
  8. Poyraz, M.; Sarı, M.; G¨uney, A.; Demirci, F.; Demirayak, S¸.; S¸ahin, E. J. Coord. Chem. 2008, 61, 3276–3283. C¸ etinkaya, B.; C¸ etinkaya, E.; K¨u¸c¨ukbay, H.; Durmaz, R. Arzneim.-Forsch./Drug Res. 1996, 46, 821–823. K¨u¸c¨ukbay, H.; Durmaz, B. Arzneim.-Forsch./Drug Res. 1997, 47, 667–670. K¨u¸c¨ukbay, H.; G¨unal, S.; Orhan, E.; Durmaz, R. Asian J. Chem. 2010, 22, 7376–7382.
  9. Galal, S. A.; Hegab, K. H.; Kassab, A. S.; Rodriguez, M. L.; Kerwin, S. M.; A. El-Khamry, A-M.; El-Diwani, H. I. Eur. J. Med. Chem. 2009, 44, 1500–1508. K¨u¸c¨ukbay, H.; C¸ etinkaya, B.; Guesmi, S.; Dixneuf, P. H. Organometallics 1996, 15, 2434–2439. K¨u¸c¨ukbay, H.; S¸ireci, N.; Yılmaz, ¨U.; Akkurt, M.; Yal¸cın, S¸. P.; Tahir, M. N.; Ott, H. Appl. Organometal. Chem. J. Inorg. Biochem. 2009, 103, 1204–1213. 21.G¨um¨u¸s, F.; Eren, G.; A¸cık, L.; C¸ elebi, A.; ¨Ozt¨urk, F.; Yılmaz, S¸.; Sa˘gkan, R. I.; G¨ur, S.; ¨Ozkul, A.; Elmalı, A.; et al. J. Med. Chem. 2009, 52, 1345–1357.
  10. Wu, H.-L.; Yun, R.-R.; Wang, K.-T.; Li, K.; Huang, X.-C.; Sun, T.; Wang, Y.-Y. J. Coord. Chem. 2010, 63, 243–249.
  11. Wang, J.; Jian, F. F.; Wang, X. J. Coord. Chem. 2009, 62, 2623–2630.
  12. Hu, F.; Yin, X.; Lu, J.; Mi, Y.; Zhuang, J; Luo, W. J. Coord. Chem. 2010, 63, 263–272. 36.Barros-Garcia, F. J.; Bernalte-Gracia, A.; Luna-Giles, F.; Maldonado-Rogado, M. A.; Vinuelas-Zahinos, E. Poly hedron 2005, 24, 1764–1772.
  13. Kwaskowska-Chec, E.; Kubiak, M.; Glowiak, T.; Ziolkowski, J. J. Transition Met. Chem. 1998, 23, 641–643.
  14. Wang, J.; Jian, F. F.; Wang, X. J. Coord. Chem. 2009, 62, 2623–2630.
  15. Bei, F.; Jian, F.; Yang, X.; Lu, L.; Wang, X.; Razak, I. A.; Raj, S. S. S.; Fun, H. K. Acta Cryst. C 2001, 57, 45–46. 40.Salas, J. M.; Romero, M. A.; Rahmani, A. Acta Cryst. C 1994, 50, 510–512. 41.Preston, H. S.; Kennard, C. H. L. J. Ch